COVID-19 vaccine effectiveness will likely drop against omicron variant, Moderna CEO says
Pfizer and Johnson & Johnson said they're also testing whether their vaccines are effective at fighting the new Omicron variant.
12 across the spectrum. Choose a side on the bar to jump to it.
National story. 17 articles from 13 sources. 12 are on the bar; 1 is an international, entertainment or tech outlet, listed separately. Updated Nov 30, 2021.
Left
3 sourcesExisting vaccines might not be effective against omicron variant right away, Moderna CEO says
Moderna says it might release a modified COVID-19 vaccine for the Omicron variant by early 2022
Moderna CEO Warns COVID-19 Shots Less Effective Against Omicron, Spooks Markets
Center
5 sourcesMarkets Drop As Moderna CEO Predicts Existing Covid-19 Vaccines Will Be Less Effective Against Omicron Variant
Stocks slip after Moderna CEO says vaccines may not work as well against Omicron
Moderna CEO Says It Will Take Months to Clear a New Covid Vaccine Targeting Omicron
Right
4 sourcesCOVID-19 vaccine effectiveness will likely drop against omicron variant, Moderna CEO says
White House responds to Moderna CEO concerns on omicron vaccine: 'we don't know yet'
Moderna CEO warns current vaccine could be less effective against omicron variant
NIH Dir. Collins: COVID vaccines will 'most likely' protect against omicron variant, but too soon to tell
Other outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
1 articleModerna CEO predicts existing COVID vaccines less effective against Omicron
Center
0 articlesNone
Right
0 articlesNone
The story so far
2 developments- Nov 28, 2021Moderna says it might release a modified COVID-19 vaccine for the Omicron variant by early 2022
- Nov 29, 2021COVID-19 vaccine effectiveness will likely drop against omicron variant, Moderna CEO says
Who covered each development
No new developments
Quiet for 1788 daysLast development · Nov 29, 2021 — COVID-19 vaccine effectiveness will likely drop against omicron variant, Moderna CEO says